Van Eck Associates Corp Cytokinetics Inc Transaction History
Van Eck Associates Corp
- $80.1 Billion
- Q3 2024
A detailed history of Van Eck Associates Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 71,691 shares of CYTK stock, worth $3.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,691
Previous 59,126
21.25%
Holding current value
$3.69 Million
Previous $3.2 Million
18.7%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$756 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$589 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$419 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$387 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$337 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.85B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...